First Condor Life Science Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
First Condor Life Science General Information
Description
Developer of immunotherapy for solid tumors intended to improve cancer treatment. The company's immunotherapy for solid tumors harnesses the patient's own immune system to target cancer cells and is uniquely designed with proprietary technology and processes, enabling medical professionals and oncology clinics to offer effective cancer treatments with fewer side effects and better patient outcomes.
Contact Information
Corporate Office
- B213, Building 1, Yinxing Zhijie Phase II, No. 1301-76 Guanguang Road, Xinlan Community
- Guanlan Street, Longhua District
- Shenzhen, Guangdong 518100
- China
Corporate Office
- B213, Building 1, Yinxing Zhijie Phase II, No. 1301-76 Guanguang Road, Xinlan Community
- Guanlan Street, Longhua District
- Shenzhen, Guangdong 518100
- China
First Condor Life Science Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 12-May-2023 | Completed | Pre-Clinical Trials |
First Condor Life Science FAQs
-
When was First Condor Life Science founded?
First Condor Life Science was founded in 2020.
-
Where is First Condor Life Science headquartered?
First Condor Life Science is headquartered in Shenzhen, China.
-
What industry is First Condor Life Science in?
First Condor Life Science’s primary industry is Pharmaceuticals.
-
Is First Condor Life Science a private or public company?
First Condor Life Science is a Private company.
-
What is First Condor Life Science’s current revenue?
The current revenue for First Condor Life Science is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process